Finally, we used the subcutaneous xenograft tumor experiment in nude mice to verify that 125I particle radiotherapy inhibits the progression of cervical cancer by promoting the HSF1/PU.1/SYK signaling pathway. This evidence concerns the gene HSF1 and cervical carcinoma.